JP2012176975A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012176975A5 JP2012176975A5 JP2012127232A JP2012127232A JP2012176975A5 JP 2012176975 A5 JP2012176975 A5 JP 2012176975A5 JP 2012127232 A JP2012127232 A JP 2012127232A JP 2012127232 A JP2012127232 A JP 2012127232A JP 2012176975 A5 JP2012176975 A5 JP 2012176975A5
- Authority
- JP
- Japan
- Prior art keywords
- tiotropium bromide
- crystal
- crystals
- pharmaceutical formulation
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 claims 15
- 229960000257 tiotropium bromide Drugs 0.000 claims 15
- 239000013078 crystal Substances 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 238000001757 thermogravimetry curve Methods 0.000 claims 2
- MQLXPRBEAHBZTK-SEINRUQRSA-M tiotropium bromide hydrate Chemical compound O.[Br-].C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 MQLXPRBEAHBZTK-SEINRUQRSA-M 0.000 claims 2
- 238000000113 differential scanning calorimetry Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 238000002411 thermogravimetry Methods 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75267205P | 2005-12-19 | 2005-12-19 | |
| US60/752,672 | 2005-12-19 | ||
| US75453005P | 2005-12-27 | 2005-12-27 | |
| US60/754,530 | 2005-12-27 | ||
| US76143706P | 2006-01-23 | 2006-01-23 | |
| US60/761,437 | 2006-01-23 | ||
| US77405106P | 2006-02-15 | 2006-02-15 | |
| US60/774,051 | 2006-02-15 | ||
| US78031006P | 2006-03-07 | 2006-03-07 | |
| US60/780,310 | 2006-03-07 | ||
| US83218906P | 2006-07-20 | 2006-07-20 | |
| US60/832,189 | 2006-07-20 | ||
| US85122306P | 2006-10-12 | 2006-10-12 | |
| US60/851,223 | 2006-10-12 | ||
| US85274006P | 2006-10-18 | 2006-10-18 | |
| US60/852,740 | 2006-10-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538130A Division JP5086267B2 (ja) | 2005-12-19 | 2006-12-19 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012176975A JP2012176975A (ja) | 2012-09-13 |
| JP2012176975A5 true JP2012176975A5 (enExample) | 2012-10-25 |
Family
ID=38115166
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538130A Active JP5086267B2 (ja) | 2005-12-19 | 2006-12-19 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
| JP2012037796A Active JP5567610B2 (ja) | 2005-12-19 | 2012-02-23 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
| JP2012127232A Pending JP2012176975A (ja) | 2005-12-19 | 2012-06-04 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538130A Active JP5086267B2 (ja) | 2005-12-19 | 2006-12-19 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
| JP2012037796A Active JP5567610B2 (ja) | 2005-12-19 | 2012-02-23 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US8163913B2 (enExample) |
| EP (2) | EP1869035B2 (enExample) |
| JP (3) | JP5086267B2 (enExample) |
| KR (1) | KR101395881B1 (enExample) |
| CN (1) | CN102731494A (enExample) |
| AT (1) | ATE552256T1 (enExample) |
| BR (1) | BRPI0608427A2 (enExample) |
| CA (1) | CA2627729A1 (enExample) |
| DK (1) | DK1869035T4 (enExample) |
| ES (2) | ES2384486T3 (enExample) |
| IL (1) | IL187947A0 (enExample) |
| MX (1) | MX2007009988A (enExample) |
| PL (2) | PL2123650T3 (enExample) |
| PT (1) | PT1869035E (enExample) |
| RS (1) | RS52663B2 (enExample) |
| TW (1) | TW200732340A (enExample) |
| WO (1) | WO2007075858A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9108962B2 (en) * | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| PT1869035E (pt) * | 2005-12-19 | 2013-01-10 | Sicor Inc | Novas formas de brometo de tiotrópio e processos para sua preparação |
| GB0716026D0 (en) | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| WO2009087419A1 (en) * | 2008-01-10 | 2009-07-16 | Generics [Uk] Limited | Novel process for the preparation of scopine esters |
| EP2172190A1 (en) * | 2008-10-02 | 2010-04-07 | Laboratorios Liconsa, S.A. | Inhalable particles comprising tiotropium |
| AU2009312582B2 (en) * | 2008-11-04 | 2014-03-27 | Cipla Limited | Tiotropium bromide having a low degree of crystallinity |
| BRPI0916047A2 (pt) * | 2008-11-04 | 2015-11-10 | Cipla Ltd | composição farmacêutica em aerossol, uso de uma composição farmacêutica em aerossol, método para tratamento de sintomas crônicos ou agudos severos, moderados ou leves, ou para tratamento profilático de um distúrbio respiratório, dispensador farmacêutico em aerossol, processo para fabricação de um dispensador farmacêutico em aerossol e processo para fabricação de um complexo de um agente ativo e um adjuvante |
| CA2768553C (en) | 2009-08-07 | 2016-08-02 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
| TR201111589A2 (tr) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür susuz kristal formu. |
| CZ304368B6 (cs) | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Směsný solvát tiotropium bromidu a způsob jeho přípravy |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| PT106142B (pt) | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
| EP2705838A1 (en) * | 2012-09-06 | 2014-03-12 | Xspray Microparticles Ab | Tiotropium preparations |
| EP2897955B1 (en) * | 2012-09-11 | 2019-11-06 | Bilgic, Mahmut | New tiotropium bromide crystalline form |
| ES2620758T3 (es) | 2012-11-05 | 2017-06-29 | Zentiva K.S. | Estabilización de solvatos de tiotropio |
| KR20150135328A (ko) | 2013-04-01 | 2015-12-02 | 풀매트릭스 인코퍼레이티드 | 티오트로피움 건조 분말 |
| EP2789611A1 (en) * | 2013-04-08 | 2014-10-15 | Cerbios-Pharma S.A. | A crystalline form of tiotropium bromide |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| RU2567539C1 (ru) * | 2015-02-04 | 2015-11-10 | Индивидуальный предприниматель Михайлов Олег Ростиславович | КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ |
| WO2017138896A1 (en) * | 2016-02-11 | 2017-08-17 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti | Crystalline form of tiotropium bromide anhydrate |
| US11365170B2 (en) | 2018-07-13 | 2022-06-21 | Kyowa Hakko Bio Co., Ltd. | Non-solvate crystal of eucomic acid and method for producing same |
| PT115583B (pt) | 2019-06-17 | 2022-05-02 | Hovione Farm S A | Processo contínuo para a preparação de medicamentos anticolinérgicos |
| EP4108230A1 (en) | 2021-06-24 | 2022-12-28 | Laboratoires SMB | New dry powder composition of tiotropium for inhalation |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US5610163A (en) | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| US6736830B2 (en) | 2000-08-22 | 2004-05-18 | Deborah M. Roust | Baby pacifier |
| US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| AU2002214996B2 (en) | 2000-10-12 | 2007-03-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| AP1712A (en) * | 2000-10-12 | 2007-01-24 | Boehringer Ingelheim Pharma | Novel tiotropium-containing inhalation powder |
| DE10064816A1 (de) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| CA2450961C (en) | 2001-06-22 | 2010-03-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6890291B2 (en) | 2001-06-25 | 2005-05-10 | Mission Medical, Inc. | Integrated automatic blood collection and processing unit |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| AU2003303029A1 (en) | 2002-12-16 | 2004-07-09 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tiotropium containing hfc solution formulations |
| UA83813C2 (ru) | 2002-12-20 | 2008-08-26 | Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг | Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола |
| DE10351196B4 (de) | 2003-10-28 | 2016-08-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verwendung einer anodisch mit Silizium bondbaren Glas-Keramik (LTCC) |
| DK1682541T3 (da) * | 2003-11-03 | 2010-06-28 | Boehringer Ingelheim Int | Fremgangsmåde til fremstilling af tiotropiumsalte |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| WO2005042527A1 (de) * | 2003-11-03 | 2005-05-12 | Boehringer Ingelheim International Gmbh | Neues kristallines anhydrat mit anticholinerger wirksamkeit |
| DK1682543T3 (da) * | 2003-11-03 | 2010-12-13 | Boehringer Ingelheim Int | Fremgangsmåde til fremstilling af nye tiotropiumsalte |
| CN1271073C (zh) | 2004-10-26 | 2006-08-23 | 江苏正大天晴药业股份有限公司 | 结晶性抗胆碱能药噻托溴铵晶体 |
| EP1879888A2 (en) * | 2005-05-02 | 2008-01-23 | Boehringer Ingelheim International GmbH | Crystalline forms of tiotropium bromide |
| KR20080012932A (ko) | 2005-05-02 | 2008-02-12 | 베링거 인겔하임 인터내셔날 게엠베하 | 티오트로퓸 브로마이드의 신규한 결정형 |
| CN101331128B (zh) * | 2005-12-19 | 2013-05-29 | 西科尔公司 | 噻托溴铵的形式及其制备方法 |
| PT1869035E (pt) * | 2005-12-19 | 2013-01-10 | Sicor Inc | Novas formas de brometo de tiotrópio e processos para sua preparação |
| EP1923393A1 (en) | 2006-11-17 | 2008-05-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Crystalline form of tiotropium bromide and urea |
| EP2020403A1 (en) * | 2007-08-02 | 2009-02-04 | Esteve Quimica, S.A. | Process for the resolution of zopiclone and intermediate compounds |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
| CA2768553C (en) | 2009-08-07 | 2016-08-02 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
-
2006
- 2006-12-19 PT PT68478874T patent/PT1869035E/pt unknown
- 2006-12-19 CN CN201210232788XA patent/CN102731494A/zh active Pending
- 2006-12-19 WO PCT/US2006/048734 patent/WO2007075858A2/en not_active Ceased
- 2006-12-19 ES ES09010563T patent/ES2384486T3/es active Active
- 2006-12-19 RS RS20120583A patent/RS52663B2/sr unknown
- 2006-12-19 CA CA002627729A patent/CA2627729A1/en not_active Abandoned
- 2006-12-19 ES ES06847887.4T patent/ES2396978T5/es active Active
- 2006-12-19 MX MX2007009988A patent/MX2007009988A/es unknown
- 2006-12-19 KR KR1020077018777A patent/KR101395881B1/ko active Active
- 2006-12-19 PL PL09010563T patent/PL2123650T3/pl unknown
- 2006-12-19 PL PL06847887T patent/PL1869035T5/pl unknown
- 2006-12-19 DK DK06847887.4T patent/DK1869035T4/en active
- 2006-12-19 US US11/643,001 patent/US8163913B2/en active Active
- 2006-12-19 TW TW095147754A patent/TW200732340A/zh unknown
- 2006-12-19 JP JP2008538130A patent/JP5086267B2/ja active Active
- 2006-12-19 AT AT09010563T patent/ATE552256T1/de active
- 2006-12-19 EP EP06847887.4A patent/EP1869035B2/en active Active
- 2006-12-19 BR BRPI0608427-3A patent/BRPI0608427A2/pt not_active IP Right Cessation
- 2006-12-19 EP EP09010563A patent/EP2123650B1/en active Active
-
2007
- 2007-12-06 IL IL187947A patent/IL187947A0/en unknown
-
2011
- 2011-12-28 US US13/339,042 patent/US8846926B2/en active Active
-
2012
- 2012-02-23 JP JP2012037796A patent/JP5567610B2/ja active Active
- 2012-03-05 US US13/412,586 patent/US20120165364A1/en not_active Abandoned
- 2012-06-04 JP JP2012127232A patent/JP2012176975A/ja active Pending
-
2013
- 2013-10-31 US US14/068,998 patent/US20140057935A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3102208T4 (fi) | 2-hydroksi-6-((2-(1-isopropyyli-1h-pyratsol-5-yyli)pyridin-3-yyli)metoksi)bentsaldehydin vapaan emäksen kiteinen polymorfi | |
| JP2014525470A5 (enExample) | ||
| JP2013237682A5 (enExample) | ||
| JP2013543867A5 (enExample) | ||
| JP2015500331A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| PH12014502363A1 (en) | N-aryltriazole compounds as lpar antagonists | |
| NZ741907A (en) | 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof | |
| ES2613716T3 (es) | Formas cristalinas de un derivado de purina | |
| JP2015044837A5 (enExample) | ||
| UA129695C2 (uk) | Спосіб отримання та кристалічні форми проміжного продукту в синтезі інгібітора mdm2 | |
| JP2012531408A5 (enExample) | ||
| IL217052A0 (en) | Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them | |
| MX2013005833A (es) | Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa. | |
| JP2014507477A5 (enExample) | ||
| JP2015522037A5 (enExample) | ||
| WO2013188283A8 (en) | Topical ophthalmological pharmaceutical composition containing sunitinib | |
| JP2016510768A5 (enExample) | ||
| NZ605827A (en) | Co-crystals and salts of ccr3-inhibitors | |
| JP2014513712A5 (enExample) | ||
| RU2016100972A (ru) | Стабильная кристаллическая форма типирацила гидрохлорида и способ ее кристаллизации | |
| JP2015516425A5 (enExample) | ||
| WO2013140265A3 (en) | Fertility enhancing agent | |
| HRP20150356T1 (hr) | Kristalni oblici soli prasugrela | |
| JP2016510767A5 (enExample) |